Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
CG Pharmaceuticals logo — A pioneering chemoproteiomics-based drug discovery and devel...

CG Pharmaceuticals

A pioneering chemoproteiomics-based drug discovery and development firm with bases in Seoul, Korea, and Emeryville, California for global clinical management

Founded 2000 2-10 employees Series B Total: $12.80M Biotechnology, Health Care +1

General Information

Company Name CG Pharmaceuticals
Founded Year 2000
Founders / Decision Makers
Team member Team member
Employees 2-10
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with CG Pharmaceuticals. To contact CG Pharmaceuticals, visit cgpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CG Pharmaceuticals compare?

A PDF of CG Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CG Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CG Pharmaceuticals

CG Pharmaceuticals, operating under the umbrella of CrystalGenomics, positions itself as a leader in the field of drug discovery through the innovative use of structural chemoproteomics. Founded in 2000, this bi-national entity boasts a presence both in Seoul, Korea, and Emeryville, California, making it well-poised for global clinical management.

The company operates within key industries including Biotechnology, Health Care, and Pharmaceutical. This strategic positioning aligns with its forward-thinking slogan of being "a pioneering chemoproteiomics-based drug discovery and development firm."

In its latest funding round, the company secured a $12.80M Series B investment on 25 June 2014 from the Global Pharmaceutical Industry Development Fund. This capital injection is indicative of strong investor confidence and supports the company's international expansion goals.

Business keywords: chemoproteomics, drug discovery, drug development, structural chemoproteomics, clinical management, CG Pharmaceuticals, multinational operations, pharmaceuticals, R&D innovation, global clinical trials, therapeutics, biopharmaceuticals, cross-border collaboration, structure-based drug design

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $12.80M -
01 Jun 2014

CG Pharmaceuticals Alternatives & Competitors

View All Alternatives
CG Pharmaceuticals vs
Santaris Pharma
Santaris Pharma

Pioneering RNA-targeted therapies with rapid LNA-based drug development for diverse disease states.

Venture round
Biotechnology, Health Care
CG Pharmaceuticals vs
BeBetter Med
BeBetter Med China

Clinical-stage drug discovery and development of advanced novel medicines for cancer and other sever...

Private Equity
5 employees
Health Care, Pharmaceutical
CG Pharmaceuticals vs
Vernalis
Vernalis United Kingdom

We develop and apply fragment and structure-based methods to solve problems in drug discovery

Venture round
260 employees
Biotechnology, Pharmaceutical
Also compare with: CG Pharmaceuticals vs InnoCare Pharma InnoCare Pharma View all alternatives

FAQ About CG Pharmaceuticals

A pioneering chemoproteiomics-based drug discovery and development firm with bases in Seoul, Korea, and Emeryville, California for global clinical management
CG Pharmaceuticals was founded in 2000.
CG Pharmaceuticals operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on chemoproteomics, drug discovery, drug development and structural chemoproteomics.
CG Pharmaceuticals has approximately 2-10 employees.
CG Pharmaceuticals has completed 1 funding round, raising a total of $12.80M. The latest funding stage is Series B.
Top alternatives and competitors to CG Pharmaceuticals include Santaris Pharma, BeBetter Med, Vernalis, Ventus Therapeutics, InnoCare Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CG Pharmaceuticals and Santaris Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CG Pharmaceuticals, https://bouncewatch.com/company/cg-pharmaceuticals, updated 7 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes